MOUNJARO vs MOUNJARO KWIKPEN
Independent side-by-side comparison.
Rating
New
New
Pharmacy pays
—
—
Type
RX
RX
Active ingredient
TIRZEPATIDE
TIRZEPATIDE
Manufacturer
Dosage forms
Injectable
Injectable
Drug class
Glp-1 Receptor Agonist
Glp-1 Receptor Agonist
Boxed warning
Half-life
about 5 days (roughly 120 hours)
about 5 days (roughly 120 hours)
Treats
Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Frequently asked questions
What is the difference between Mounjaro and Mounjaro Kwikpen?
Both Mounjaro and Mounjaro Kwikpen share the active ingredient Tirzepatide.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.